For 40 years, Amgen has championed a spirit of innovation that has contributed to our longevity as a leading biotechnology company – providing for patients in more than 100 countries around the world. Our nearly 23,000 employees work every day to ensure we serve every patient, every time.

In order to fulfill our mission, our employees work collaboratively with a mutual trust and respect to push the boundaries of science to deliver new therapies and medications to our patients. This includes fostering a culture that is welcoming and inclusive of diverse ideas and unique perspectives.

As we constantly push our employees to innovate and improve, we must also do so as a company. Diversity, Inclusion and Belonging (DI&B) is a leading business priority for Amgen. Our goal is to increase the percentage of women in leadership globally and minority representation in the United States.  We have worked to deploy several programs and strategies to create a more diverse and inclusive workplace for our staff and maximize opportunities for their development.  As with our aspiration to be the best human therapeutic company, we remain committed to ensuring that Amgen is the best place for diverse talent to thrive.  In turn, we recognize that this will only strengthen the culture of innovation for Amgen as we work to serve our patients.

We are on a journey to build a culture of diversity, inclusion and belonging. We are making progress on that journey through a set of integrated actions.

Highlights of Recent Actions

  • Enhanced resources and leadership dedicated to DI&B 
    • Our DI&B Council reports to the CEO and consists of the CEO direct reports.  
    • Our 10 Employee Resource Groups (ERGs) at Amgen are organized around diverse groups that support business objectives.
    • Our 10 ERGs are sponsored by the most senior Amgen executives.
    • 4,000 staff members participate in our ERGs.
  • Continued focus on women in leadership and minority representation
    • Women comprise 52% of our global workforce and 39% of our executive levels.
    • Minorities comprise 48% of our US and Puerto Rico workforce and 28% of our executive levels.
  • Surveyed employees consistently on staff engagement and diversity, inclusion and belonging
  • Conducted reviews of pay, performance and promotion equity for gender and minorities
  • Established DI&B training for managers
  • Increased Amgen staff members sharing stories of inclusion, careers, accomplishments and life inside and outside of Amgen
  • Invested in addressing healthcare disparities
    • Partnered with Lazarex and the Amgen Community Oncology Research Collaborators (ACORC) to assist low income and diverse patients with participation in clinical trials. 
    • Launched an informational website dedicated to African American patients with multiple myeloma, which received a 2019 Pharma Choice Award in the multicultural category.

Amgen continues to receive external recognition for our culture, including placement on the Forbes Best Employers for Diversity and achieving a 100 percent score on the Corporate Equality Index.

See information about Amgen’s Forward-Looking Statements here.

Report Homepage